InMed Pharmaceuticals Showcases INM-901 at Biotech Webinar
Company Announcements

InMed Pharmaceuticals Showcases INM-901 at Biotech Webinar

InMed Pharmaceuticals ( (INM) ) has shared an announcement.

InMed Pharmaceuticals is set to participate in the Fierce Biotech webinar on Alzheimer’s neuroinflammation, showcasing their drug candidate, INM-901. This innovative compound aims to mitigate neuroinflammation and promote brain cell communication, positioning InMed as a leader in Alzheimer’s research. The event will feature leading experts discussing breakthrough therapies, offering valuable insights for investors and stakeholders in the biotech sector.

For an in-depth examination of INM stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskInMed Pharmaceuticals’ New Alzheimer’s Treatment Patent
TipRanks Auto-Generated NewsdeskInMed Pharmaceuticals Strengthens Team with Alzheimer’s Expert
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App